Nebulizer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Global Nebulizer Market is segmented by Type (Pneumatic Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer), Portability (Tabletop Nebulizer and Portable Nebulizer), Sales Channel (Direct Purchase and Online Purchase), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

nebulizer market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.45 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global nebulizer market is expected to grow with an CAGR of 6.45% during the forecast period of 2021-2026.  

The COVID-19 pandemic is expected to have a significant impact on the market. There has been an increased use of albuterol inhalers in hospitals for COVID-19 and suspected COVID-19 patients to help with their respiratory issues. This is mainly because respiratory viruses are the most common trigger for asthma complications and nebulizers help to provide relief. Furthermore, older people are more vulnerable to respiratory diseases, such as chronic obstructive pulmonary disease (COPD), sleep apnea, and the COVID-19, due to many factors, including the gradual decline of immune function. Most of the patients affected with COVID-19 are elderly. According to the American Lung Association (ALA) in 2020, nebulized therapy is a safe and effective way to manage COPD at home for patients during COVID-19. Thus, this has led to the growing demand for nebulizers.

There are certain factors that are driving the market growth, including rising incidences of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base.

Chronic respiratory diseases are diseases that affect the airways and other parts of the lungs. Respiratory symptoms are among the leading causes of consultation with doctors and physicians in primary healthcare centers. Some of the major preventable chronic respiratory disorders are asthma, chronic obstructive pulmonary disease (COPD), allergic rhinitis, sleep apnea, and tuberculosis (principally, multi-drug resistant tuberculosis). Tobacco smoking is one of the primary causes of the increase in respiratory diseases across the world. Another reason for the increased prevalence of respiratory diseases is the excessive environmental pollution in metropolitan cities and industrial lands. In addition, second-hand smoke exposure leads to severe respiratory diseases. Chronic respiratory diseases affect more than 1 billion people globally, as per the Global Asthma Report, 2018. In addition, as per the Global Tuberculosis Report 2019, the incidence of TB in low-income regions was higher during 2018, whereas in the developed regions, it was comparatively low. The report suggested that the incidence of TB in Africa was around 2,450,000, whereas, in the Americas, it was 289,000. The rising respiratory diseases and other respiratory diseases, such as pneumonia and lung cancer, have been the major causes for the rise in hospitalization rates, especially in the low- and middle-income countries. According to the International Agency for Research on Cancer published Globocan 2020 report, the total number of new lung cancer cases in the year 2020 was 2 206 771. This high incidence of lung cancer is increasing disease burden. This has led to an increase in demand for nebulizers.

Scope of the Report

Nebulizer is a medical device that converts the drug into mist and delivers it directly to the lungs. The technique of nebulization is commonly used for the treatment of respiratory diseases, including asthma, cystic fibrosis, and COPD. There are various devices that can be used for nebulization. Some of the devices are rechargeable, and electrically powered ones are the most widely used.

The Global Nebulizer Market is segmented by Type (Pneumatic Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer), Portability (Tabletop Nebulizer and Portable Nebulizer), Sales Channel (Direct Purchase and Online Purchase), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Type
Pneumatic Nebulizer
Ultrasonic Nebulizer
Mesh Nebulizer
By Portability
Tabletop Nebulizer
Portable Nebulizer
Sales Channel
Direct Purchase
Online Purchase
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Pneumatic Nebulizer Segment is Expected to Hold a Significant Share

Pneumatic nebulizer has the potential to deliver the drug in the form of droplets in the size range of 1-5 mm, with the help of baffles incorporated into its design. These nebulizers are mostly used for bronchodilator administration to produce a physiological response. Both technical and patient factors are involved in the performance of pneumatic nebulizers. Technical factors, like the gas flow used to power the nebulizer, the volume of the nebulizer solution, and the nebulizer output, play a crucial role in better drug delivery. The condition of the patient is also crucial for effective drug delivery by the pneumatic nebulizers. Factors, like the breathing patterns, airway obstruction, and positive pressure delivery of the patient, determine the performance of the pneumatic nebulizers. Hence, the low cost of pneumatic nebulizers is also driving its demand among end-user settings. This, in turn, is expected to drive the pneumatic nebulizer segment over the forecast period.

Moreover, the rising adoption of pneumatic nebulizers due to their convenience and effectiveness is expected to influence the growth positively. According to the study of Analytica Chimica Acta, in 2020, a pneumatic nebulizer was used for introducing metallic, ionic meta calibrant solutions and nanoparticles. These factors are expected to boost market growth.

Prevalence of Asthma

North America Dominates the Market and is Expected to do so over the Forecast Period

The North American nebulizer market is growing, due to the continuous innovations in technology. As the population in the region follows a fast-moving lifestyle, patients are looking for more portable nebulizer devices that can be transferred easily in time of need for patients suffering from asthma and other airway diseases. The United States is the largest market in the North America region.

The burden of respiratory diseases, such as tuberculosis, COPD, and sleep apnea, is increasing in the United States, which is fueling the demand for nebulizers across the country. According to the Centers for Disease Control and Prevention (CDC), in 2019, an estimated 25,131,132 million Americans had asthma, including 8% of adults and 7% of children. The statistics represented a large number of people who were suffering from asthma, which propels the demand for nebulizers in the country. 

Moreover, several mergers, acquisitions, partnerships, and product launches by the market players also positively influence overall market growth. For example, in June 2020, Respira Technologies announced the launch of a pharmaceutical-focused commercial development program for its RespiRx drug-delivery device platform which is a portable, handheld vibrating mesh nebulizer. Additionally, in June 2020, the company Renovion had raised USD 8.1 million in funding for the clinical development of ARINA-1 (ascorbic acid), which is an experimental nebulizer therapy to clear mucus and reduce inflammation in people with non-cystic fibrosis bronchiectasis and cystic fibrosis. These factors are expected to boost the growth of Nebulizer market in the United States.

Nebulizer Market-geo

Competitive Landscape

The nebulizer market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, various strategies, such as mergers and acquisitions, product approvals, and agreements, are being adopted by these key market players to increase the outreach of their products and strengthen their product portfolios. Some of the market players are Agilent Technologies, VYAIRE MEDICAL, INC, Drive DeVilbiss Healthcare, Rossmax International Ltd., and GF Health Products Inc.

Recent Developments

In March 2021, PARI Pharma GmbH, announced the authorization of the LAMIRA Nebulizer System for delivery of Insmed's drug product ARIKAYCE in Japan.

In December 2020, AireHealth announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its connected nebulizer. The device is a portable, electronic vibrating mesh nebulizer designed to nebulize liquid medications for inhalation by a patient in and out of the home. 

In July 2020, OMRON Healthcare announced the launch of OMRON NE C106, its new compressor nebulizer in India.

Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidences of Chronic Respiratory Diseases

      2. 4.2.2 Increasing Demand for Home Healthcare Devices

      3. 4.2.3 Rising Geriatric Population Base

    3. 4.3 Market Restraints

      1. 4.3.1 Drug Loss during Drug Delivery

    4. 4.4 Industry Attractiveness Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Pneumatic Nebulizer

      2. 5.1.2 Ultrasonic Nebulizer

      3. 5.1.3 Mesh Nebulizer

    2. 5.2 By Portability

      1. 5.2.1 Tabletop Nebulizer

      2. 5.2.2 Portable Nebulizer

    3. 5.3 Sales Channel

      1. 5.3.1 Direct Purchase

      2. 5.3.2 Online Purchase

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies

      2. 6.1.2 VYAIRE MEDICAL, INC

      3. 6.1.3 Rossmax International Ltd.

      4. 6.1.4 Drive DeVilbiss Healthcare

      5. 6.1.5 GF Health Products Inc.

      6. 6.1.6 Invacare Corporation

      7. 6.1.7 Koninklijke Philips NV

      8. 6.1.8 Medline Industries Inc.

      9. 6.1.9 Omron Corporation

      10. 6.1.10 PARI Pharma

      11. 6.1.11 Air Liquide Medical Systems

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Nebulizer Market market is studied from 2018 - 2026.

The Global Nebulizer Market is growing at a CAGR of 6.45% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Agilent Technologies, VYAIRE MEDICAL, INC, Drive DeVilbiss Healthcare, GF Health Products Inc., Rossmax International Ltd. are the major companies operating in Global Nebulizer Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!